Quote | CNS Pharmaceuticals Inc. (NYSE:CNSP)
Last: | $ |
---|---|
Change Percent: | 0.24% |
Open: | $4.15 |
Close: | $4.11 |
High: | $4.2986 |
Low: | $4.10 |
Volume: | 44,730 |
Last Trade Date Time: | 02/12/2020 04:44:03 pm |
News | CNS Pharmaceuticals Inc. (NYSE:CNSP)
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in next month’s 2024 SNO/ASCO CNS Cancer Conference. The event will be held...
HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its ab...
Message Board Posts | CNS Pharmaceuticals Inc. (NYSE:CNSP)
Subject | By | Source | When |
---|---|---|---|
$CNSP news all the way baby | StockLogistics | investorshub | 05/06/2023 5:40:01 AM |
My bad, still 2 Mill, I was looking | Sun Dance Kid | investorshub | 05/04/2023 11:38:10 PM |
Did the OS just double? Or did E-Trade | Sun Dance Kid | investorshub | 05/04/2023 11:34:30 PM |
NetworkNewsWire: NetworkNewsBreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Retains Analytics Firm, | NetworkNewsWire | investorshangout | 05/03/2023 8:05:01 PM |
Any ideas? | KeepOn | investorshub | 05/03/2023 1:48:41 PM |
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
CNS Pharmaceuticals Inc. Website:
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in next month’s 2024 SNO/ASCO CNS Cancer Conference. The event will be held...
HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its ab...
New research suggests that cancer may have been plaguing individuals even thousands of years ago. Researchers at the University of Cambridge’s Duckworth Laboratory Collection studied skulls obtained from Ancient Egypt, observing lesions which they believe may have been left by malignant t...